Simcyp, a division of Certara, said this week that it has entered into a Cooperative Research and Development Agreement with the US Food and Drug Administration to further develop the Simcyp Dog model for the evaluation of drug products intended for use in different canine breeds.

Over the next five years, Simcyp and researchers at the FDA's Center for Veterinary Medicine will develop physiologically based pharmacokinetic dog models that will help streamline the process of veterinary drug product development and evaluation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.